| # | Drug | Count |
|---|---|---|
| 0 | LEVOTHYROXINE SODIUM | 2288 |
| 1 | LEVOTHYROXINE SODIUM ANHYDROUS | 570 |
| 2 | PEMBROLIZUMAB | 396 |
| 3 | ERGOCALCIFEROL | 394 |
| 4 | ASPIRIN | 345 |
| 5 | ASPIRIN 325 MG | 332 |
| 6 | ASPIRIN 81 MG | 332 |
| 7 | NIVOLUMAB | 257 |
| 8 | ACETAMINOPHEN | 254 |
| 9 | FUROSEMIDE | 237 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIFEPRISTONE | 68 | 0.0142 |
| 1 | ERGOCALCIFEROL | 394 | 0.0133 |
| 2 | ALEMTUZUMAB | 194 | 0.0100 |
| 3 | THYROID, PORCINE | 100 | 0.0093 |
| 4 | LIOTHYRONINE SODIUM | 75 | 0.0086 |
| 5 | LEVOTHYROXINE SODIUM | 2288 | 0.0075 |
| 6 | TEPROTUMUMAB | 43 | 0.0072 |
| 7 | LEVOTHYROXINE SODIUM ANHYDROUS | 570 | 0.0056 |
| 8 | DIMENHYDRINATE | 56 | 0.0052 |
| 9 | LENVATINIB | 173 | 0.0052 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 730 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 670 |
| 2 | Kinase Inhibitor [EPC] | 485 |
| 3 | Benzodiazepine [EPC] | 408 |
| 4 | Provitamin D2 Compound [EPC] | 394 |
| 5 | Corticosteroid [EPC] | 382 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 349 |
| 7 | Proton Pump Inhibitor [EPC] | 322 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 300 |
| 9 | Loop Diuretic [EPC] | 276 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Stimulating Hormone [EPC] | 18 | 0.0173 |
| 1 | Progestin Antagonist [EPC] | 68 | 0.0142 |
| 2 | Provitamin D2 Compound [EPC] | 394 | 0.0132 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 194 | 0.0100 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 730 | 0.0074 |
| 5 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 43 | 0.0072 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 13 | 0.0063 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 24 | 0.0025 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 18 | 0.0017 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 75 | 0.0016 |